Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6263113 | 1.00 | TRPV1 (0.51) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL31678748 | 1.00 | TRPV1 (0.51) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL9419767 | 0.98 | TRPV1 (0.50) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL10405653 | 0.98 | TRPV1 (0.50) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL9770419 | 0.98 | TRPV1 (0.50) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL11484335 | 0.98 | TRPV1 (0.50) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL10405654 | 0.98 | TRPV1 (0.50) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL10921446 | 0.90 | CTSK (0.45) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL10921443 | 0.90 | CTSK (0.45) | TRPV1CTSKPTGS1KMT2APGR | |
| SCHEMBL11484782 | 0.87 | CTSK (0.43) | TRPV1CTSKPTGS1KMT2APGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270152-A1 | PROCESS FOR PREPARING beta-FARNESENES AND 2-(3-ALKENYL)-1,3-BUTADIENE COMPOUND HAVING RELATED STRUCTURE, AND SYNTHETIC INTERMEDIATE COMPOUND THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| CN-114874072-A | Preparation method of geranylgeraniol | 广西民族师范学院 | 2022-08-09 | — | — | CN | disclosed |
| EP-1072589-B1 | Process for producing lycopene and intermediate thereof | SUMITOMO CHEMICAL CO (JP) | 2005-11-09 | — | — | EP | disclosed |
| CN-1158253-C | Process for preparing prolycopene and its intermediate | ס�ѻ�ѧ��ҵ��ʽ���� | 2004-07-21 | — | — | CN | disclosed |
| EP-0983998-B1 | Tetraene derivative and process for producing the same | SUMITOMO CHEMICAL CO (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-6331652-B1 | Process for producing lycopene and intermediate thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-12-18 | — | — | US | disclosed |
| EP-0881204-B1 | Polyene alcohol derivative and process for producing the same | SUMITOMO CHEMICAL CO (JP) | 2001-11-14 | — | — | EP | disclosed |
| CN-1286247-A | Process for preparing prolycopene and its intermediate | SUMITOMO CHEMICAL CO (JP) | 2001-03-07 | — | — | CN | disclosed |
| EP-1072589-A2 | Process for producing lycopene and intermediate thereof | Sumitomo Chemical Company, Limited (JP) | 2001-01-31 | — | — | EP | disclosed |
| US-6087541-A | Polyene alcohol derivative and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-07-11 | — | — | US | disclosed |
| EP-0282915-B1 | PROCESS FOR PREPARING SULFONE COMPOUNDS | KURARAY CO., LTD. (JP) | 1991-04-17 | — | — | EP | disclosed |
| EP-0421419-A2 | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Bristol-Myers Squibb Company (US) | 1991-04-10 | — | — | EP | disclosed |
| US-4886916-A | REACTING (GERANYL, NERYL, OR LINALYL) CHLORIDE WITH ALKALI METAL PHENYL SULFINATE | KURARAY COMPANY, LTD. (JP) | 1989-12-12 | — | — | US | disclosed |
| EP-0282915-A1 | Process for preparing sulfone compounds | KURARAY CO., LTD. (JP) | 1988-09-21 | — | — | EP | disclosed |
| EP-0243849-A2 | Process for the production of polyprenoid type compounds | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1987-11-04 | — | — | EP | disclosed |
| US-4613571-A | OXIDATION BY NOCARDIA | ESAI CO., LTD. (JP) | 1986-09-23 | — | — | US | disclosed |
| EP-0067938-B1 | POLYPRENYL SULFONE DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR USES | Eisai Co., Ltd. (JP) | 1984-12-27 | — | — | EP | disclosed |
| US-4449002-A | CHEMICAL INTERMEDIATES FOR ANTIULCER AND HYPOTENSIVE AGENTS SUCH AS COENZYME Q10 | EISAI CO., LTD. (JP) | 1984-05-15 | — | — | US | disclosed |
| EP-0067938-A1 | Polyprenyl sulfone derivatives, process for producing them and their uses | Eisai Co., Ltd. (JP) | 1982-12-29 | — | — | EP | disclosed |
| US-4199531-A | Intermediates for the production of quinones | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1980-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270152-A1 | PROCESS FOR PREPARING beta-FARNESENES AND 2-(3-ALKENYL)-1,3-BUTADIENE COMPOUND HAVING RELATED STRUCTURE, AND SYNTHETIC INTERMEDIATE COMPOUND THEREOF | GGPS1, HSD3B1, HSD3B2 | TRPV1 2338/4885CTSK 3747/4885PTGS1 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.